Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractIron deficiency is a common cause of morbidity and can arise as a consequence or complication from many diseases. The use of intravenous iron has increased significantly in the last decade, but concerns remain about indications and administration. Modern intravenous iron preparations can facilitate rapid iron repletion in one or two doses, both for absolute iron deficiency and, in the presence of inflammation, functional iron deficiency, where oral iron therapy is ineffective or has not worked. A multidisciplinary team of experts experienced in iron deficiency undertook a consensus review to support healthcare professionals with practical advice on managing iron deficiency in gastrointestinal, renal and cardiac disease, as well as; pregnancy, heavy menstrual bleeding, and surgery. We explain how intravenous iron may work where oral iron has not. We provide context on how and when intravenous iron should be administered, and informed opinion on potential benefits balanced with potential side-effects. We propose how intravenous iron side-effects can be anticipated in terms of what they may be and when they may occur. The aim of this consensus is to provide a practical basis for educating and preparing staff and patients on when and how iron infusions can be administered safely and efficiently.Key messages Iron deficiency treatment selection is driven by several factors, including the presence of inflammation, the time available for iron replenishment, and the anticipated risk of side-effects or intolerance. Intravenous iron preparations are indicated for the treatment of iron deficiency when oral preparations are ineffective or cannot be used, and therefore have applicability in a wide range of clinical contexts, including chronic inflammatory conditions, perioperative settings, and disorders associated with chronic blood loss. Adverse events occurring with intravenous iron can be anticipated according to when they typically occur, which provides a basis for educating and preparing staff and patients on how iron infusions can be administered safely and efficiently.
CitationRichards, T., Breymann, C., Brookes, M.J. et al. (2021) Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Annals of Medicine, 53(1), pp. 274-285.
PublisherTaylor & Francis
JournalAnnals of Medicine
PubMed ID33426933 (pubmed)
Description© 2021 The Authors. Published by Taylor & Francis. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1080/07853890.2020.1867323
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution 4.0 International
- Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.
- Authors: Richards T, Breymann C, Brookes MJ, Lindgren S, Macdougall IC, McMahon LP, Munro MG, Nemeth E, Rosano GMC, Schiefke I, Weiss G
- Issue date: 2021 Dec
- Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron.
- Authors: Auerbach M
- Issue date: 2018 Jun 22
- Treatments for iron-deficiency anaemia in pregnancy.
- Authors: Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A
- Issue date: 2011 Oct 5
- Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
- Authors: Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B
- Issue date: 2015 Apr